ArticleMedicine2026
Efficacy and safety of one-stop Angiojet mechanical thrombectomy combined with iliac vein stenting in May-Thurner syndrome complicated with acute iliofemoral deep vein thrombosis.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
May-Thurner Syndrome (MTS) with acute iliofemoral deep vein thrombosis (IFDVT) carries high risks of limb ischemia and post-thrombotic syndrome (PTS). Traditional treatments like catheter-directed thrombolysis have limitations, including high major bleeding risk and prolonged hospital stays. A retrospective cohort study included 52 patients with MTS-related acute IFDVT (one-stop group: 27, Angiojet mechanical thrombectomy + simultaneous iliac vein stenting; traditional group: 25, catheter-directed thrombolysis alone or with delayed stenting). Main outcomes were 24-hour limb circumference edema reduction rate, 6-month iliac vein patency (stenosis <30%), 6-month PTS (Villalta score ≥5), and severe bleeding. Baseline limb swelling was comparable between the 2 groups (all P > .05). The one-stop group had better 24-hour limb circumference edema reduction rate (15 cm above knee: 82.2 ± 4.9% vs 73.6 ± 2.4%; 15 cm below knee: 70.0 ± 8.2% vs 58.5 ± 7.4% in the traditional group, both P < .01), higher 6-month patency (81.48% vs 32.00%, P < .001), lower PTS incidence (11.11% vs 76.00%, P < .001), and less severe bleeding (3.70% vs 24.00%, P < .05). The one-stop strategy offers superior early swelling relief, significantly higher 6-month iliac vein patency (81.48% vs 32.00%, P < .001), lower PTS risk, and better safety for MTS-related IFDVT, supporting it as a preferred clinical option.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.